Using its economic leverage, California has been forging its own path on scientific research for 25 years. Here’s how.
Morning Overview on MSNOpinion
AI expert warned of 2027 doom, now he’s moving the date
For a brief moment, a single year crystallised the most apocalyptic fears about artificial intelligence: 2027. A research ...
By adopting a Data-First approach, you can build connected intelligence while providing AI analysis to automate ...
In August 1810, at the height of the Anglo-Napoleonic wars, a small French fleet based in Mauritius did something unexpected: ...
An in-depth analysis of PFAS sources, environmental persistence, and health risks, emphasizing the significant role of ...
Phase 3 SELVA study evaluating QTORIN rapamycin 3.9% anhydrous gel (QTORIN rapamycin) for microcystic lymphatic malformations (microcystic LMs) remains on track, with topline results anticipated in Ma ...
Morning Overview on MSN
AI still needs 1 major breakthrough to hit superintelligence, builders say
Artificial intelligence systems can now write code, summarize legal contracts, and help design new drugs, yet the people ...
President Donald Trump’s January 7 Memorandum, announcing the United States’ withdrawal from 66 international organisations, marks one of the most consequential ruptures in the global climate governan ...
PDS Biotech Submits Amended Protocol for Phase 3 VERSATILE-003 Trial Constructive Type C Meeting Provides Potential Pathway to Accelerated Approval of PDS0101 PRINCETON, N.J., Jan. 09, 2026 (GLOBE NEW ...
Phase 3 SELVA study evaluating QTORIN™ rapamycin 3.9% anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic ...
Phase 3 SELVA study evaluating QTORIN™ rapamycin 3.9% anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic ...
Google and Character.AI, an artificial intelligence firm (AI), agreed Wednesday to settle a lawsuit linked to a teen’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback